BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9003747)

  • 1. Induction of IL-2 and IFN-gamma in BALB/c mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine.
    Tamizifar H; Jennings R; Ali SA; Potter CW
    J Med Microbiol; 1997 Jan; 46(1):61-6. PubMed ID: 9003747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response and protection against influenza A infection in mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine.
    Tamizifar H; Robinson A; Jennings R; Potter CW
    Vaccine; 1995 Nov; 13(16):1539-46. PubMed ID: 8578839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response of mice to immunization with subunit influenza A vaccine in DTP vaccine.
    Potter CW; Tamizifar H; Jennings R
    Vaccine; 1995 Feb; 13(3):253-60. PubMed ID: 7631510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
    Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of an acellular pertussis vaccine booster in 15- to 20-month-old children previously immunized with acellular or whole-cell pertussis vaccine as infants.
    Pichichero ME; Francis AB; Marsocci SM; Green JL; Disney FA; Meschievitz C
    Pediatrics; 1993 Apr; 91(4):756-60. PubMed ID: 8464662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting induction of peripheral IFN-γ recall response to influenza A virus vaccination in pigs.
    Olson ZF; Sandbulte MR; Souza CK; Perez DR; Vincent AL; Loving CL
    Vet Immunol Immunopathol; 2017 Mar; 185():57-65. PubMed ID: 28242003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acellular pertussis vaccination of 2-month-old infants in the United States.
    Pichichero ME; Francis AB; Blatter MM; Reisinger KS; Green JL; Marsocci SM; Disney FA
    Pediatrics; 1992 May; 89(5 Pt 1):882-7. PubMed ID: 1579399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
    Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action.
    Caproni E; Tritto E; Cortese M; Muzzi A; Mosca F; Monaci E; Baudner B; Seubert A; De Gregorio E
    J Immunol; 2012 Apr; 188(7):3088-98. PubMed ID: 22351935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re.
    Song X; Chen J; Sakwiwatkul K; Li R; Hu S
    Int Immunopharmacol; 2010 Mar; 10(3):351-6. PubMed ID: 20034596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.
    Quintilio W; Kubrusly FS; Iourtov D; Miyaki C; Sakauchi MA; Lúcio F; Dias Sde C; Takata CS; Miyaji EN; Higashi HG; Leite LC; Raw I
    Vaccine; 2009 Jun; 27(31):4219-24. PubMed ID: 19393709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings--a blinded comparison of commercially available vaccines.
    Gildea S; Quinlivan M; Murphy BA; Cullinane A
    Vaccine; 2013 Oct; 31(45):5216-22. PubMed ID: 24021309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor-alpha, interleukin-1 alpha, interleukin-2 and interferon-gamma on the immunogenicity of an inactivated rabies vaccine.
    Schijns VE; Claassen IJ; Vermeulen AA; Horzinek MC; Osterhaus AD
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():55-63. PubMed ID: 8113740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytokines induced by experimental anti-tetanus immunization. Vaccine formulation effect].
    Castro M; Mateo N; Lavigne V; Deluchi S; Atzori C; Piudo L; Brero ML; Manghi M
    Medicina (B Aires); 2002; 62(2):154-8. PubMed ID: 12038038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent and synergistic effects of interleukin-18 and interleukin-12 in augmenting cytotoxic T lymphocyte responses and IFN-gamma production in aging.
    Zhang Y; Wang Y; Gilmore X; Xu K; Mbawuike IN
    J Interferon Cytokine Res; 2001 Oct; 21(10):843-50. PubMed ID: 11710997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the kinesis of immune responses in mice vaccinated by different kinds of recombinant hepatitis B vaccines].
    Hu ZY; He P; Fang X; Qiu SH; Liang ZL; Li HM; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):810-4. PubMed ID: 19103120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
    Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.